A blood-based signature of cerebrospinal fluid Aβ<sub>1-42</sub> status.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37149-7
- By:
- Publication type:
- Article
Works by The Alzheimer's Disease Metabolomics Consortium
Results: 4
1
2
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04011-6
- By:
- Publication type:
- Article
3
Uncovering neural substrates across Alzheimer's disease stages using contrastive variational autoencoder.
- Published in:
- Cerebral Cortex, 2024, v. 34, n. 10, p. 1, doi. 10.1093/cercor/bhae393
- By:
- Publication type:
- Article
4
Integrating multi-omics summary data using a Mendelian randomization framework.
- Published in:
- Briefings in Bioinformatics, 2022, v. 23, n. 6, p. 1, doi. 10.1093/bib/bbac376
- By:
- Publication type:
- Article